News
CCM Biosciences identifies novel enzyme activators with applications in longevity space
Published: 29 January 2025
Founded by 9I制作厂免费 Desautels Associate Professor Anisha Ghosh, with over $25 million in funding, CCM Biosciences is developing novel therapeutics in longevity. Recently, the company announced that it has developed an enzyme activator that can restore activity to youthful levels. This breakthrough has the potential to lead to drug development candidates for age-related disorders like Alzheimer鈥檚 and Parkinson鈥檚 Disease.
听
Feedback
For more information or if you would like to report an error, please web.desautels [at] mcgill.ca (subject: Website%20News%20Comments) (contact us).
